The Role of Medications in the Treatment of Adolescents and Young Adults with Opioid Use Disorder (Banta-Green C & Cooley L, 2018), a report for ADAI, reviews the current research about treatment medications and young adults along with important real world insights from expert prescribers and substance use treatment providers.
Treatment of Opioid Use Disorders in Youth, provides an overview of treating opioid use disorder in adolescents. Dr. Marc Fishman discusses the use of the medications naltrexone and buprenorphine, as well as family engagement and behavioral approaches in this training sponsored by the UW’s Psychiatry and Addictions Case Conference series.
Dr. Fishman is board certified in addiction psychiatry and addiction medicine. He is a member of the Psychiatry faculty of the Johns Hopkins University School of Medicine, and Medical Director of Maryland Treatment Centers.
Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose (Bagley et al, Ann Emerg Med 2020; 75(1):29-38.) describes characteristics of young adults, 18-25, who experience nonfatal overdose and explores the time to starting medications for OUD. This is one of the few research studies focused on real world medication for OUD access among young adults. They found that about one-third of people who had an overdose received treatment medications within a year and that the medication they received varied by age.